Discover open access scientific publications

Search, annotate, share and cite publications

Publications by WJ Ramsey

Safety and Immunogenicity of the rVSV∆G-ZEBOV-GP Ebola Virus Vaccine Candidate in Healthy Adults: A Phase 1b Randomised, Multicentre, Double-Blind, Placebo-Controlled, Dose-Response Study

The Lancet Infectious Diseases

Infectious Diseases

2017

English

Related publications

Safety and Immunogenicity of a Recombinant Adenovirus Type-5 Vector-Based Ebola Vaccine in Healthy Adults in Sierra Leone: A Single-Centre, Randomised, Double-Blind, Placebo-Controlled, Phase 2 Trial

The Lancet

Medicine

2017

English

One-Year Safety of the Rvsv∆g-Zebov-Gp Vaccine in Adolescents and Children in Lambarene, Gabon

English

A Phase 2/3 Double Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Immunogenicity of a Seasonal Trivalent Inactivated Split-Virion Influenza Vaccine (IVACFLU-S) in Healthy Adults in Vietnam

Human Vaccines and Immunotherapeutics

English

Immunity Duration of a Recombinant Adenovirus Type-5 Vector-Based Ebola Vaccine and a Homologous Prime-Boost Immunisation in Healthy Adults in China: Final Report of a Randomised, Double-Blind, Placebo-Controlled, Phase 1 Trial

The Lancet Global Health

Medicine

2017

English

Safety and Immunogenicity of a Parenteral P2-Vp8-P[8] Subunit Rotavirus Vaccine in Toddlers and Infants in South Africa: A Randomised, Double-Blind, Placebo-Controlled Trial

The Lancet Infectious Diseases

Infectious Diseases

2017

English

Diclofenac Patch for Topical Treatment of Acute Impact Injuries: A Randomised, Double Blind, Placebo Controlled, Multicentre Study

British Journal of Sports Medicine

English

Randomised, Double-Blind, Placebo-Controlled Trial of EPs 7630 in Adults With COPD

English

Efficacy and Safety of Analgesic Treatment for Depression in People With Advanced Dementia: Randomised, Multicentre, Double-Blind, Placebo-Controlled Trial (DEP.PAIN.DEM)

English

A 6-Week, Multicentre, Randomised, Double-Blind, Double-Dummy, Active-Controlled, Clinical Safety Study of Lumiracoxib and Rofecoxib in Osteoarthritis Patients

BMC Musculoskeletal Disorders

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by WJ Ramsey

Safety and Immunogenicity of the rVSV∆G-ZEBOV-GP Ebola Virus Vaccine Candidate in Healthy Adults: A Phase 1b Randomised, Multicentre, Double-Blind, Placebo-Controlled, Dose-Response Study

Related publications

Safety and Immunogenicity of a Recombinant Adenovirus Type-5 Vector-Based Ebola Vaccine in Healthy Adults in Sierra Leone: A Single-Centre, Randomised, Double-Blind, Placebo-Controlled, Phase 2 Trial

One-Year Safety of the Rvsv∆g-Zebov-Gp Vaccine in Adolescents and Children in Lambarene, Gabon

A Phase 2/3 Double Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Immunogenicity of a Seasonal Trivalent Inactivated Split-Virion Influenza Vaccine (IVACFLU-S) in Healthy Adults in Vietnam

Immunity Duration of a Recombinant Adenovirus Type-5 Vector-Based Ebola Vaccine and a Homologous Prime-Boost Immunisation in Healthy Adults in China: Final Report of a Randomised, Double-Blind, Placebo-Controlled, Phase 1 Trial

Safety and Immunogenicity of a Parenteral P2-Vp8-P[8] Subunit Rotavirus Vaccine in Toddlers and Infants in South Africa: A Randomised, Double-Blind, Placebo-Controlled Trial

Diclofenac Patch for Topical Treatment of Acute Impact Injuries: A Randomised, Double Blind, Placebo Controlled, Multicentre Study

Randomised, Double-Blind, Placebo-Controlled Trial of EPs 7630 in Adults With COPD

Efficacy and Safety of Analgesic Treatment for Depression in People With Advanced Dementia: Randomised, Multicentre, Double-Blind, Placebo-Controlled Trial (DEP.PAIN.DEM)

A 6-Week, Multicentre, Randomised, Double-Blind, Double-Dummy, Active-Controlled, Clinical Safety Study of Lumiracoxib and Rofecoxib in Osteoarthritis Patients